Form D · Biotechnology
Asterias Biotherapeutics, Inc.
Menlo Park, CA · CIK 0001572552
Offering snapshot reported Feb 23, 2015 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 9, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2015 | Initial | $4,000,000 | No comparison | 0 | SEC filing |
| Jun 20, 2014 | Initial | $0 | No comparison | 2 | SEC filing |
| Jun 19, 2014 | Initial | $936,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-234539
Source: Form D, filed Feb 23, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Arno | Director |
| Alfred D Kingsley | Director |
| Jane S Lebkowski | Executive |
| Richard T. Le Buhn | Director |
| Pedro Lichtinger | Director, Executive |
| Robert W Peabody | Director, Executive |
| Natale Ricciardi | Director |
| Judith Segall | Director, Executive |
| Katharine Spink | Executive |
| Michael D West | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
230 Constitution Drive
Menlo Park, CA, 94025
Menlo Park, CA, 94025